EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

The Effect of the COVID-19 Pandemic on Prescribing Medications for Opioid Use Disorder in the Mid-Michigan Region

Nooshin C Beygui iD, Erin Duross iD, Chin-I Cheng iD, Katherine Mesaros iD, Karissa Gawronski iD, Juliette Perzhinsky iD

Journal of Primary Care & Community Health · 2025

DOI: 10.1177/21501319251331322 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Primary Care & Community Health, 2025. Verfasst von Nooshin C Beygui und 5 weiteren Autor:innen. Beteiligte Einrichtung: Central Michigan University College of Medicine, Mt. Pleasant, MI, USA. Hauptthemen laut MEDLINE: COVID-19, Opioid-Related Disorders, Practice Patterns, Physicians'. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Central Michigan College of Medicine Summer Research Scholar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The increasing prevalence of opioid use coupled with the emergence of the Coronavirus Disease-19 (COVID-19) pandemic impacted opioid overdoses and death rates. People with opioid use disorder (OUD) are particularly vulnerable to the pandemic’s consequences. Although Medications for Opioid Use Disorder (MOUD) are the most well supported treatment for OUD, they remain underutilized by clinicians, particularly in the primary care setting, emphasizing the importance of examining factors that impact prescribing.

Objective

To assess clinicians’ prescribing practices for MOUD and assess the pandemic’s effect on MOUD prescription. To determine whether there is an association between patient-specific factors, such as mental health diagnoses and substance use disorder (SUD), and MOUD prescription practices prior to and during the COVID-19 pandemic.

Methods

A retrospective chart review assessed 500 patient charts with a diagnosis of OUD to assess demographics, MOUD prescribing, substance use, and co-morbid mental health conditions.

Results

312 charts met inclusion criteria. There was no significant difference in the percentage of new MOUD prescriptions among the selected cohort between the 2 selected timeframes, nor was there a significant difference in the prescriber/setting of new prescriptions. Cumulative analysis revealed that greater than 2/3 of the selected patients had concurrent mental health diagnoses. Greater than 50% of patients reported active non-opioid substance use. The odds of having a co-occurring SUD were significantly higher among patients treated in the emergency department and various treatment settings—including urgent care and non-primary care clinics—as compared to the primary care outpatient setting.

Conclusions

Strong evidence supports the efficacy of using MOUD in primary care, yet it is underutilized in the mid-Michigan region. Overall prevalence of mental health diagnoses, SUD, MOUD prescriber practices were similar prior to and during the COVID-19 pandemic. There was a high occurrence of co-occurring SUD especially among patients treated outside of the primary care setting. Future initiatives to increase clinician education around MOUD and address patient barriers to treatment are warranted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Opioid-Related DisordersPractice Patterns, Physicians'HumansMaleFemaleRetrospective StudiesAdultMiddle AgedPandemicsPrimary Health CareAnalgesics, OpioidSARS-CoV-2Drug PrescriptionsComorbidityMental Disorders

Stichwörter der Autor:innen

coronavirus disease 2019 (COVID-19)medication-assisted treatment (MAT)medications for opioid use disorder (MOUD)opioid use disordersubstance use

Substanzen

Analgesics, Opioid

Autor:innen und Institutionen

  • Central Michigan University College of Medicine, Mt. Pleasant, MI, USA.
  • Central Michigan University College of Science and Technology, Mt. Pleasant, MI, USA.

ORCID-Profile: Nooshin C Beygui, Erin Duross, Chin-I Cheng, Katherine Mesaros, Karissa Gawronski, Juliette Perzhinsky

Förderung

  • Central Michigan College of Medicine Summer Research Scholar

Zitieren

APA

Beygui, N. C., Duross, E., Cheng, C. I., Mesaros, K., Gawronski, K., & Perzhinsky, J. (2025). The Effect of the COVID-19 Pandemic on Prescribing Medications for Opioid Use Disorder in the Mid-Michigan Region. Journal of Primary Care & Community Health. https://doi.org/10.1177/21501319251331322

Vancouver

Beygui NC, Duross E, Cheng CI, Mesaros K, Gawronski K, Perzhinsky J. The Effect of the COVID-19 Pandemic on Prescribing Medications for Opioid Use Disorder in the Mid-Michigan Region. Journal of Primary Care & Community Health. 2025. doi:10.1177/21501319251331322

BibTeX
@article{Beygui2025,
  author = {Beygui, Nooshin C and Duross, Erin and Cheng, Chin-I and Mesaros, Katherine and Gawronski, Karissa and Perzhinsky, Juliette},
  title = {The Effect of the COVID-19 Pandemic on Prescribing Medications for Opioid Use Disorder in the Mid-Michigan Region},
  journal = {Journal of Primary Care & Community Health},
  year = {2025},
  doi = {10.1177/21501319251331322}
}
Kostenlos starten →